What’s new

• Sampre Nutritions reported a standalone net profit of ₹3.87 cr for FY26 versus a net loss of ₹7.31 cr in FY25.
• Annual revenue from operations grew 72.5% to ₹43.35 cr.
• The board approved the results; statutory auditors gave an unmodified opinion.

Why it matters

This is a genuine operational turnaround. Revenue almost doubled, and the company erased a ₹7.31 cr loss. For a nano-cap with a ₹113 cr market cap, the scale of the swing is proportionally large. The unmodified audit opinion adds credibility to the numbers.

What we’re watching

• Whether the international subsidiary contributes to FY27 numbers.
• If the manufacturing volume gains translate into sustained margins.
• The stock's reaction to a rare profit in its recent history.

The full read

Sampre Nutritions delivered a clear turnaround in FY26. The confectionery maker posted a standalone net profit of ₹3.87 crore, swinging from a ₹7.31 crore loss the prior year. The catalyst was a 72.5% surge in revenue to ₹43.35 crore, which the company says came from improved manufacturing volumes. For a nano-cap with a ₹113 crore market capitalization, the reversal is proportionally large. The results are also the first to include consolidated numbers for the new international subsidiary, Sampre Nutritions FZCO, though the filing doesn't break out its performance separately. Statutory auditors signed off with an unmodified opinion. The key question is whether this pace of revenue growth can be sustained and whether it translates into durable margins.

Primary source: BSE · NSE